External Advisory Committee

The External Advisory Committee (EAC) is responsible for assessing scientific progress across the PCBC. This charge includes both progress within the PCBC components, as well as the functionality of interactions between the Research Hubs, the ACC, and the Cores. The EAC will attend the annual PCBC Investigators’ meeting, and provide feedback to NHLBI on PCBC progress on an annual basis. In addition, the EAC will carry out a formal review of the PCBC at the mid-point of the program, during the fourth year of funding. The EAC also serves as the review panel for the distribution of funds set-aside through the ACC for Cores, Pilot Studies, and Ancillary and Collaborative Studies. The EAC will review applications submitted through the ACC in response to PCBC RFAs, and make recommendations to NHLBI for funding. NHLBI Program staff will determine funding based on the EAC reviews and consideration of programmatic balance.

CHAIRMAN

Victor Dzau, M.D.

President & CEO, DUHS

Chancellor for Health Affairs

Duke University Medical Center

Durham, NC 27710

MEMBERS

Hal E. Broxmeyer, Ph.D.

Distinguished Professor 

Professor of Microbiology/Immunology

Indiana University Simon Cancer Center

1030 W. Michigan St., R2 302

Indianapolis, IN  46202

Wellington Cardoso, M.D., Ph.D.

Professor of Medicine & Pathology

Director, Lung Development Program

Boston University School of Medicine

Boston, MA 02118

Kyunghee Choi, Ph.D.

Associate Professor

Department of Pathology & Immunology

Washington University School of Medicine

St. Louis, MO 63110

Robert D. Simari, M.D.

Professor of Medicine

Vice Chair, Division of Cardiovascular Diseases, Department of Biochemistry

& Molecular Biology

Mayo Clinic College of Medicine

Rochester, MN 55905

Gordana Vunjak-Novakovic, Ph.D.

Professor of Biomedical Engineering

The Fu Foundation School of Engineering & Applied Science / Columbia University
510 S.W. Mudd Building / 500 West 120th Street / New York, New York 10027

CHAIRMAN’S OFFICE REPRESENTATIVE

Maria Mirotsou, M.D.

Assistant Professor

Cardiovascular Medicine

Duke University Medical Center

Durham, NC 27710

PROGRAM REPRESENTATIVES

Denis Buxton, Ph.D.

Associate Director, Basic and Early Translational Research Program

National Heart, Lung, & Blood Institute

Bethesda, MD 20892

John Thomas, Ph.D.

Stem Cell and Cell-based Therapy 

Coordinator, Division of Blood Diseases

and Resources

Transfusion Medicine & Cellular  

Therapeutics Branch     

National Heart, Lung, & Blood Institute    

Bethesda, MD 20892

SCIENTIFIC REVIEW ADMINISTRATOR

Michael Terrin, M.D., C.M., M.P.H.

Director, NHLBI PCBC Administrative Coordinating Center (PCACC)

University of Maryland School of Medicine

Baltimore, MD 21201